Faiçal Isbaine joined DIXI medical as our new Director Clinical Development
Creation of a scientific direction and appointment of John Gale as Chief Scientific Officer
We are pleased to announce the creation of a new scientific direction within DIXI medical. This direction will play a key role in the development of the company by ensuring that its activities are based on solid scientific foundations.
Appointment of John Gale as Chief Scientific Officer
To lead this new direction, John Gale has been promoted to Chief Scientific Officer. Formerly Vice President of DIXI NeuroLab, John brings a wealth of experience and recognized expertise in neuroscience.
An accomplished researcher, he has published numerous reference articles in prestigious journals, contributing to major advances in the understanding of neurodegenerative diseases and the development of new therapies. John Gale is an invaluable asset to the company, and his appointment testifies to DIXI medical’s commitment to scientific excellence and innovation.
Faical Isbaine joins as Director-Clinical Development
John will be supported by Faical Isbaine as Director-Clinical Development. Faical is an expert neurophysiologist, trained in the electrophysiology of neurodegenerative diseases in both France and the USA under the mentorship of John Gale.
Faical possesses extensive knowledge in imaging techniques. Prior to joining Dixi medical, he served as an intraoperative neurophysiologist and medical image analyst at Emory University, one of North America’s most prestigious neurosurgical centers. By joining hands with John Gale, they will ensure a state-of-the-art scientific approach to addressing technical challenges and innovations.
Roles and Responsibilities of the Scientific Direction
The main mission of the scientific direction will be to guide the improvement of products, launch new products and projects, understand and evaluate new medical practices as well as new competitors. It will also provide support to DIXI medical’s commercial services in the preparation of their information and training work. In addition, it will act as a service unit for the Quality and Regulatory Affairs Department.
We are pleased to announce the creation of a new scientific direction within DIXI medical...
At DIXI medical, we are proud to support the continuing and specialized education of healthcare professionals in the field of epilepsy.
We are delighted to announce the arrival of our new VP Research & Development, Pierre Fridez.
We are thrilled to announce that Health Canada has approved thermocoagulation procedures as an extension of the intended use of our depth electrodes.
John Gale, renowned Neurophysiologist, Vice President of DIXI NeuroLab, launches an insightful 6-Episode webinar on the inner workings of the human brain and microelectrode recordings.
MEET KILLIAN PEIER! Killian Peier is a Swiss ski-jumping athlete, silver medallist at the World Championships in 2018. DIXI is proud to
PASSION AND DEDICATION In those uncertain times, some things remain unchanged… our passion and dedication!It might be ski jumping, or manufacturing intracerebral
A BIT OF FRESH AIR… We all love Summertime! ? But we also do like to have a short and refreshing break
EPILEPSYX.NET DIXI medical is very proud to support EpilepsyX.Net. This initiative is made by and for Doctors and Healthcare Professional Treating Epilepsy Care
NEW MEMS SEEG ELECTRODE Exciting news for the future of SEEG electrodes! Click on the link here: https://www.globenewswire.com/news-release/2021/07/06/2257955/0/en/Adept-Neuro-Reaches-Key-Milestone-in-the-Development-of-Novel-Intracerebral-Stereoelectroencephalography-SEEG-Electrodes.html Video template title Video
KILLIAN IS BACK IN THE AIR? Killian did his first jump since his injury! We are delighted to know him back in
EPILEPSY AWARENESS MONTH? November is Epilepsy Awareness Month. It is time to exchange, share information, and raise awareness together. Video template title Video
MICRODEEP® MICRO-MACRO DEPTH ELECTRODE We are very happy to announce that the MICRODEEP® Micro-Macro Electrode is now FDA cleared. A unique multi-contact, flexi-rigid
NEUROPACE ANNOUNCES DISTRIBUTION AGREEMENT WITH DIXI MEDICAL USA NeuroPace Announces Distribution Agreement with DIXI Medical USA, Provider of Intracranial Electrodes and Instruments